LYME DISEASE

EPIDEMIOLOGY

Slide 3

Slide 4

EPIDEMIOLOGY (cont)

MAJOR RISK FACTORS

CLINICAL MANIFESTATIONS

ACUTE INFECTION

DISSEMINATED DISEASE

DISSEMINATED (cont)

Slide 11

DISSEMINATED (cont)

DISSEMINATED (cont)

CHRONIC - LATE PERSISTENT

CHRONIC (cont)

NATURAL HISTORY

Slide 17

CONCURRENT INFECTIONS

DIFFERENTIAL DIAGNOSIS

DIFFERENTIAL (cont)

DIAGNOSIS

EARLY DISEASE (cont)

Slide 23

Slide 24

EARLY DISEASE (cont)

EARLY DISEASE (cont)

DISSEMINATED DISEASE

LATE DISEASE

ANTIBODY TESTING

TESTING(cont)

TESTING (cont)

TREATMENT

PREVENTION

VACCINATION

WEST NILE VIRUS

INFECTIOUS AGENT

INCUBATION PERIOD/SYMPTOMS

TREATMENT

DIFFERENTIAL DIAGNOSIS

TESTING

"Must report suspected cases of..."

INFECTIOUS MONONUCLEOSIS

EPIDEMIOLOGY

"Chance of acute EBV infection..."

OTHER CAUSES OF IM

CLINICAL MANIFESTIONS

"Less common clinical features"

DIAGNOSTIC TESTING

"If heterophil antibody continues neg..."

LABORATORY ABNORMALITIES

IM IN OLDER ADULTS

MANAGEMENT

CHRONIC FATIGUE SYNDROME

ETIOLOGY

DIAGNOSTIC CRITERIA (PER CDC)

"Symptom Criteria"

"Exclusion Criteria"

"Detailed medical history"

MANAGEMENT

PHARMACOTHERAPY

NONPHARMACOLOGIC TREATMENT

DIFFERENTIAL

PSYCHIATRIC CONDITIONS EXCLUDING CFS DIAGNOSIS

HERPES ZOSTER

COMMON DISTRIBUTION

PRESENTATION/DIAGNOSIS

Slide 67

Slide 68

POTENTIAL COMPLICATIONS

TREATMENT

POSTHERPETIC NEURALGIA